Works by Weber, Jeffrey

Results: 107
    1
    2
    3
    4

    Introduction.

    Published in:
    Oncology (08909091), 2008, v. 22, p. 9
    By:
    • Weber, Jeffrey
    Publication type:
    Article
    5
    6
    7
    8

    Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

    Published in:
    OncoTargets & Therapy, 2017, v. 10, p. 4239, doi. 10.2147/OTT.S136992
    By:
    • Creelan, Ben C.;
    • Gabrilovich, Dmitry I.;
    • Gray, Jhanelle E.;
    • Williams, Charles C.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Weber, Jeffrey S.;
    • Gibney, Geoffrey T.;
    • Markowitz, Joseph;
    • Proksch, Joel W.;
    • Reisman, Scott A.;
    • McKee, Mark D.;
    • Chin, Melanie P.;
    • Meyer, Colin J.;
    • Antonia, Scott J.
    Publication type:
    Article
    9
    10
    11
    12
    13

    Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03697-3
    By:
    • Moser, Justin C.;
    • Bhatia, Shailender;
    • Amin, Asim;
    • Pavlick, Anna C.;
    • Betts, Keith A.;
    • Du, Ella Xiaoyan;
    • Poretta, Tayla;
    • Shelley, Karishma;
    • Srinivasan, Swetha;
    • Sakkal, Leon Alan;
    • Palaia, Jennell;
    • Lobo, Maurice;
    • Pe Benito, Melanie;
    • Linton, Joshua A.;
    • Chen, Yan;
    • Xu, Churong;
    • Yin, Lei;
    • Sundar, Manasvi;
    • Weber, Jeffrey
    Publication type:
    Article
    14

    Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 4, p. 945, doi. 10.1007/s00262-022-03302-5
    By:
    • Weber, Jeffrey S.;
    • Poretta, Tayla;
    • Stwalley, Brian D.;
    • Sakkal, Leon A.;
    • Du, Ella X.;
    • Wang, Travis;
    • Chen, Yan;
    • Wang, Yan;
    • Betts, Keith A.;
    • Shoushtari, Alexander N.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae033
    By:
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Kohn, Amiee;
    • Tawbi, Hussein;
    • Weber, Jeffrey;
    • Flaherty, Keith;
    • McArthur, Grant A;
    • Ascierto, Paolo A;
    • Pfluger, Yanina;
    • Lewis, Karl;
    • Tsai, Katy K;
    • Hamid, Omid;
    • Prenen, Hans;
    • Fein, Luis;
    • Wang, Erjian;
    • Guenzel, Carolin;
    • Zhang, Fan;
    • Kleha, Joseph F;
    • Pietro, Alessandra di;
    • Davies, Michael A
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38573-8
    By:
    • Li, Xiaolong;
    • Singh, Nishant Kumar;
    • Collins, David R.;
    • Ng, Robert;
    • Zhang, Angela;
    • Lamothe-Molina, Pedro A.;
    • Shahinian, Peter;
    • Xu, Shutong;
    • Tan, Kemin;
    • Piechocka-Trocha, Alicja;
    • Urbach, Jonathan M.;
    • Weber, Jeffrey K.;
    • Gaiha, Gaurav D.;
    • Takou Mbah, Overbeck Christian;
    • Huynh, Tien;
    • Cheever, Sophia;
    • Chen, James;
    • Birnbaum, Michael;
    • Zhou, Ruhong;
    • Walker, Bruce D.
    Publication type:
    Article
    38

    Nanoparticle-based modulation of CD4<sup>+</sup> T cell effector and helper functions enhances adoptive immunotherapy.

    Published in:
    Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33597-y
    By:
    • Isser, Ariel;
    • Silver, Aliyah B.;
    • Pruitt, Hawley C.;
    • Mass, Michal;
    • Elias, Emma H.;
    • Aihara, Gohta;
    • Kang, Si-Sim;
    • Bachmann, Niklas;
    • Chen, Ying-Yu;
    • Leonard, Elissa K.;
    • Bieler, Joan G.;
    • Chaisawangwong, Worarat;
    • Choy, Joseph;
    • Shannon, Sydney R.;
    • Gerecht, Sharon;
    • Weber, Jeffrey S.;
    • Spangler, Jamie B.;
    • Schneck, Jonathan P.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy).

    Published in:
    Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04325-x
    By:
    • Ascierto, Paolo A.;
    • Agarwala, Sanjiv S.;
    • Warner, Allison Betof;
    • Ernstoff, Marc S.;
    • Fox, Bernard A.;
    • Gajewski, Thomas F.;
    • Galon, Jérôme;
    • Garbe, Claus;
    • Gastman, Brian R.;
    • Gershenwald, Jeffrey E.;
    • Kalinski, Pawel;
    • Krogsgaard, Michelle;
    • Leidner, Rom S.;
    • Lo, Roger S.;
    • Menzies, Alexander M.;
    • Michielin, Olivier;
    • Poulikakos, Poulikos I.;
    • Weber, Jeffrey S.;
    • Caracò, Corrado;
    • Osman, Iman
    Publication type:
    Article